vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $90.3M, roughly 1.7× Evolus, Inc.). On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs 3.6%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $11.3M). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs 5.1%).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
EOLS vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.3M | $151.1M |
| Net Profit | $130.0K | — |
| Gross Margin | 65.7% | 17.8% |
| Operating Margin | 4.7% | 2.3% |
| Net Margin | 0.1% | — |
| Revenue YoY | 14.4% | 3.6% |
| Net Profit YoY | 101.9% | — |
| EPS (diluted) | $0.01 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.3M | $151.1M | ||
| Q3 25 | $69.0M | $126.8M | ||
| Q2 25 | $69.4M | $132.5M | ||
| Q1 25 | $68.5M | $135.7M | ||
| Q4 24 | $78.9M | $145.8M | ||
| Q3 24 | $61.1M | $122.3M | ||
| Q2 24 | $66.9M | $130.8M | ||
| Q1 24 | $59.3M | $136.8M |
| Q4 25 | $130.0K | — | ||
| Q3 25 | $-15.7M | $1.6M | ||
| Q2 25 | $-17.1M | $-17.2M | ||
| Q1 25 | $-18.9M | $7.8M | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-19.2M | $4.7M | ||
| Q2 24 | $-11.3M | $8.3M | ||
| Q1 24 | $-13.1M | $7.1M |
| Q4 25 | 65.7% | 17.8% | ||
| Q3 25 | 66.5% | 15.1% | ||
| Q2 25 | 65.3% | 3.9% | ||
| Q1 25 | 68.1% | 22.0% | ||
| Q4 24 | 66.7% | 22.8% | ||
| Q3 24 | 68.9% | 18.5% | ||
| Q2 24 | 70.3% | 22.3% | ||
| Q1 24 | 68.3% | 21.5% |
| Q4 25 | 4.7% | 2.3% | ||
| Q3 25 | -16.7% | -2.7% | ||
| Q2 25 | -14.7% | -15.6% | ||
| Q1 25 | -22.1% | 6.2% | ||
| Q4 24 | -2.9% | 7.8% | ||
| Q3 24 | -25.3% | 3.1% | ||
| Q2 24 | -11.5% | 6.9% | ||
| Q1 24 | -15.0% | 5.5% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | -22.8% | 1.2% | ||
| Q2 25 | -24.7% | -13.0% | ||
| Q1 25 | -27.6% | 5.7% | ||
| Q4 24 | -8.6% | — | ||
| Q3 24 | -31.4% | 3.9% | ||
| Q2 24 | -17.0% | 6.3% | ||
| Q1 24 | -22.1% | 5.2% |
| Q4 25 | $0.01 | $0.22 | ||
| Q3 25 | $-0.24 | $0.10 | ||
| Q2 25 | $-0.27 | $-1.05 | ||
| Q1 25 | $-0.30 | $0.46 | ||
| Q4 24 | $-0.11 | $0.62 | ||
| Q3 24 | $-0.30 | $0.28 | ||
| Q2 24 | $-0.18 | $0.47 | ||
| Q1 24 | $-0.22 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.8M | $92.5M |
| Total DebtLower is stronger | $146.1M | — |
| Stockholders' EquityBook value | $-23.1M | $283.8M |
| Total Assets | $225.9M | $342.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.8M | $92.5M | ||
| Q3 25 | $43.5M | $80.8M | ||
| Q2 25 | $61.7M | $101.4M | ||
| Q1 25 | $67.9M | $108.3M | ||
| Q4 24 | $87.0M | $105.5M | ||
| Q3 24 | $85.0M | $96.0M | ||
| Q2 24 | $93.7M | $105.6M | ||
| Q1 24 | $97.0M | $115.3M |
| Q4 25 | $146.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $121.8M | — | ||
| Q4 24 | $121.5M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $120.9M | — | ||
| Q1 24 | $120.6M | — |
| Q4 25 | $-23.1M | $283.8M | ||
| Q3 25 | $-28.8M | $279.6M | ||
| Q2 25 | $-18.7M | $289.3M | ||
| Q1 25 | $-6.6M | $321.5M | ||
| Q4 24 | $5.5M | $319.6M | ||
| Q3 24 | $5.9M | $314.9M | ||
| Q2 24 | $19.3M | $321.5M | ||
| Q1 24 | $18.4M | $332.0M |
| Q4 25 | $225.9M | $342.0M | ||
| Q3 25 | $219.0M | $342.3M | ||
| Q2 25 | $228.8M | $349.5M | ||
| Q1 25 | $213.4M | $379.0M | ||
| Q4 24 | $232.6M | $384.0M | ||
| Q3 24 | $229.6M | $373.5M | ||
| Q2 24 | $233.8M | $376.7M | ||
| Q1 24 | $226.2M | $385.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 22.00× | — | ||
| Q3 24 | 20.58× | — | ||
| Q2 24 | 6.26× | — | ||
| Q1 24 | 6.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.8M | $15.5M |
| Free Cash FlowOCF − Capex | $11.3M | $12.3M |
| FCF MarginFCF / Revenue | 12.6% | 8.2% |
| Capex IntensityCapex / Revenue | 1.6% | 2.1% |
| Cash ConversionOCF / Net Profit | 98.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.7M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.8M | $15.5M | ||
| Q3 25 | $-14.7M | $12.9M | ||
| Q2 25 | $-24.8M | $14.7M | ||
| Q1 25 | $-15.6M | $11.1M | ||
| Q4 24 | $4.8M | $20.0M | ||
| Q3 24 | $-5.7M | $9.4M | ||
| Q2 24 | $-6.5M | $18.7M | ||
| Q1 24 | $-10.6M | $7.3M |
| Q4 25 | $11.3M | $12.3M | ||
| Q3 25 | $-15.6M | $7.0M | ||
| Q2 25 | $-25.5M | $9.1M | ||
| Q1 25 | $-16.0M | $10.0M | ||
| Q4 24 | $4.4M | $16.4M | ||
| Q3 24 | $-6.0M | $2.6M | ||
| Q2 24 | $-6.9M | $10.1M | ||
| Q1 24 | $-10.9M | $5.6M |
| Q4 25 | 12.6% | 8.2% | ||
| Q3 25 | -22.7% | 5.5% | ||
| Q2 25 | -36.7% | 6.9% | ||
| Q1 25 | -23.3% | 7.4% | ||
| Q4 24 | 5.5% | 11.2% | ||
| Q3 24 | -9.9% | 2.1% | ||
| Q2 24 | -10.4% | 7.7% | ||
| Q1 24 | -18.3% | 4.1% |
| Q4 25 | 1.6% | 2.1% | ||
| Q3 25 | 1.4% | 4.6% | ||
| Q2 25 | 1.0% | 4.2% | ||
| Q1 25 | 0.5% | 0.8% | ||
| Q4 24 | 0.6% | 2.5% | ||
| Q3 24 | 0.5% | 5.5% | ||
| Q2 24 | 0.7% | 6.6% | ||
| Q1 24 | 0.4% | 1.3% |
| Q4 25 | 98.67× | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
Segment breakdown not available.
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
